Inve US ▾
BIBIO

What Bio-Rad Laboratories promised, and what happened

Guidance Tracker · every commitment management made on a call, tracked from the quarter it was made

Guidance

What management said, and what became of it

14 of 24 judged targets kept · 26 open · verdicts reflect calls analysed to Jun 2026.

TargetOriginal wordingSaidLatest callVerdict
Currency-neutral revenue growth0.5% to 1.5%Dec 2025Jun 2026:We continue to expect full year currency-neutral revenue growth to be between minus 3% and plus 0.5%.
Call transcript, Jun 2026 · no direct link		Revised Down
ddPCR business revenue growthmid-single digitDec 2025Jun 2026:we still see near-term mid-single-digit kind of growth rate from a ddPCR standpoint.
Call transcript, Jun 2026 · no direct link		On Track

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

The full ledger

Open Bio-Rad Laboratories’s full ledger

A free account opens 5 company ledgers a month. All 50 tracked commitments, with each call’s wording and source.

US Pro opens 100 a month, first month free →

The rest of the ledger

Pro opens all 50 tracked commitments for Bio-Rad Laboratories

Above is what the last two calls moved. Pro adds every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

Upgrade to Pro, one month free